Cargando…
Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947690/ https://www.ncbi.nlm.nih.gov/pubmed/35328161 http://dx.doi.org/10.3390/diagnostics12030608 |
| _version_ | 1784674499448274944 |
|---|---|
| author | Schramm, Laura |
| author_facet | Schramm, Laura |
| author_sort | Schramm, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8947690 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89476902022-03-25 Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364 Schramm, Laura Diagnostics (Basel) Comment MDPI 2022-02-28 /pmc/articles/PMC8947690/ /pubmed/35328161 http://dx.doi.org/10.3390/diagnostics12030608 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Comment Schramm, Laura Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364 |
| title | Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364 |
| title_full | Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364 |
| title_fullStr | Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364 |
| title_full_unstemmed | Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364 |
| title_short | Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364 |
| title_sort | comment on li et al. bdp1 variants i1264m and v1347m significantly associated with clinical outcomes of pediatric neuroblastoma patients imply a new prognostic biomarker: a 121-patient cancer genome study. diagnostics 2021, 11, 2364 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947690/ https://www.ncbi.nlm.nih.gov/pubmed/35328161 http://dx.doi.org/10.3390/diagnostics12030608 |
| work_keys_str_mv | AT schrammlaura commentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 |